Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Palisade Bio Q3 EPS $(0.38) Misses $(0.27) Estimate

Author: Benzinga Newsdesk | November 10, 2025 05:50pm
Palisade Bio (NASDAQ:PALI) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0.27) by 39.19 percent. This is a 83.62 percent increase over losses of $(2.32) per share from the same period last year.

Posted In: PALI


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist